Covetrus (CVET) Cut to Sell at Zacks Investment Research

Covetrus (NASDAQ:CVET) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday, Zacks.com reports.

According to Zacks, “Covetrus, Inc. provides animal-health technology and services. The Company combines practice management software, prescription management, multi-channel client engagement services and supply chain infrastructure to promote connectivity between veterinarians and their clients. Covetrus, Inc. is based in NY, United States. “

CVET has been the topic of a number of other reports. Raymond James assumed coverage on shares of Covetrus in a research note on Wednesday, February 27th. They set an “outperform” rating and a $45.00 price target on the stock. Credit Suisse Group assumed coverage on shares of Covetrus in a research note on Thursday, April 4th. They set a “neutral” rating and a $35.00 price target on the stock. William Blair assumed coverage on shares of Covetrus in a research note on Tuesday, February 12th. They set an “outperform” rating on the stock. Finally, Svb Leerink restated an “outperform” rating on shares of Covetrus in a research note on Wednesday, March 20th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $40.00.

Shares of CVET stock traded down $0.31 during trading on Friday, reaching $32.65. 714,413 shares of the company’s stock traded hands, compared to its average volume of 1,630,119. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.91 and a current ratio of 1.90. Covetrus has a 1 year low of $30.71 and a 1 year high of $43.83.

Covetrus Company Profile

Covetrus, Inc engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY.

Featured Article: Average Daily Trade Volume – ADTV

Get a free copy of the Zacks research report on Covetrus (CVET)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.